Registration will be closed at 12:00 PM on Tuesday, May 30, 2023.
After the online registration is closed, please visit on-site to register. Please email ccpd@mednet.ucla.edu or call 310-794-2620 for other assistance. 

Faculty Info (PDF)

Resources (PDF)

COURSE DESCRIPTION

UCLA has been a leader in AIDS and HIV-related research, education and patient care since 1981 when the nation’s first cases of AIDS were identified at the UCLA Medical Center. The UCLA Center for Clinical AIDS Research and Education (CARE Center) was established in 1990 to facilitate clinical research and to integrate current research findings with teaching and patient care.

The UCLA CARE Center manages an outpatient clinic dedicated to patients with HIV and maintains an active clinical research program, which evaluates new antiretroviral therapies and investigates diseases associated with HIV and the complications of therapy. It is one of the original sites of the Adult AIDS Clinical Trials Group (ACTG). An education and outreach program disseminates information on AIDS and HIV infection to healthcare providers and to the community.

The CARE Center is also a primary location for training of medical students and house staff at the David Geffen School of Medicine at UCLA in the optimal care of patients with HIV.

Target Audience

Physicians (MD/DO), nurse practitioners (NP), physician assistants (PA-c), fellows, and previously attended participants. 

REGISTRATION INFORMATION

Registration will be closed at 1:00 PM on Tuesday, May 30, 2023.
After the online registration is closed, please visit on-site to register. Please email ccpd@mednet.ucla.edu or call 310-794-2620 for other assistance.

Course Fees

$45

Refund

Due to the low enrollment fee, no refunds will be provided. 

Questions

Regarding enrollment or CME-related questions: Call (310) 794-2620 or email ccpd@mednet.ucla.edu.

Regarding program-related questions: Contact the Program Coordinator at (310) 825-6413 or email at caresymposium@mednet.ucla.edu.

EXHIBITOR INFORMATION

Please email ccpd@mednet.ucla.edu.

OBJECTIVES

Upon completion of the program, participants will be able to:

• Anticipate the strategies that contributed to the trajectory of the 2022 MPOX epidemic
• Describe how to initiate screening for and treatment of patients with current substance-use
• Identify novel strategies for STI prevention
• Describe the challenges in implementation of novel HIV Prevention Strategies, and what we can do to advocate for change.
• Identify current thinking on how to optimize ART in the setting of pregnancy, and prevention of Mother-to-Child transmission of HIV

ACCREDITATION

The David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The David Geffen School of Medicine at UCLA, designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURES

The FDA has issued a concept paper that classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is “truly independent” and free of commercial influence. In addition to independence, the FDA requires that non-promotional, commercially supported education be objective, balanced and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program’s participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manage all identified potential conflicts of interest prior to the program. UCLA fully endorses the letter and spirit of these concepts.